Current Assets
Allowance for Doubtful Accounts
Edwards Lifesciences Allowance for Doubtful Accounts increased by 4.0% to $15.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $12.60M to $15.60M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts shows an upward trend with a 9.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase suggests rising credit risk or economic stress among the customer base.
Detailed definition
A contra-asset account that represents the estimated portion of accounts receivable that the company does not expect to...
Peer comparison
Standard across all utilities; levels are often influenced by regulatory mandates regarding service disconnection policies.
Metric ID:
allowance_for_doubtful_accountsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.00M | $9.50M | $9.30M | $8.70M | $8.60M | $7.50M | $7.90M | $7.60M | $8.10M | $7.90M | $8.20M | $13.50M | $13.90M | $12.60M | $11.60M | $12.60M | $12.70M | $12.60M | $15.00M | $15.60M |
| QoQ Change | — | +5.6% | -2.1% | -6.5% | -1.1% | -12.8% | +5.3% | -3.8% | +6.6% | -2.5% | +3.8% | +64.6% | +3.0% | -9.4% | -7.9% | +8.6% | +0.8% | -0.8% | +19.0% | +4.0% |
| YoY Change | — | — | — | — | -4.4% | -21.1% | -15.1% | -12.6% | -5.8% | +5.3% | +3.8% | +77.6% | +71.6% | +59.5% | +41.5% | -6.7% | -8.6% | +0.0% | +29.3% | +23.8% |
Range$7.50M – $15.60M
CAGR+12.3%
Avg YoY Growth+14.9%
Median YoY Growth+1.9%
Current Streak2 quarters growth
Allowance for Doubtful Accounts at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's allowance for doubtful accounts?
- Edwards Lifesciences (EW) reported allowance for doubtful accounts of $15.60M in Q1 2026.
- How has Edwards Lifesciences's allowance for doubtful accounts changed year-over-year?
- Edwards Lifesciences's allowance for doubtful accounts increased by 23.8% year-over-year, from $12.60M to $15.60M.
- What is the long-term trend for Edwards Lifesciences's allowance for doubtful accounts?
- Over 5 years (2020 to 2025), Edwards Lifesciences's allowance for doubtful accounts has grown at a 9.3% compound annual growth rate (CAGR), from $9.60M to $15.00M.
- What does allowance for doubtful accounts mean?
- The estimated amount of customer debt that the company expects will not be paid.